JP2020502498A5 - - Google Patents

Download PDF

Info

Publication number
JP2020502498A5
JP2020502498A5 JP2019528092A JP2019528092A JP2020502498A5 JP 2020502498 A5 JP2020502498 A5 JP 2020502498A5 JP 2019528092 A JP2019528092 A JP 2019528092A JP 2019528092 A JP2019528092 A JP 2019528092A JP 2020502498 A5 JP2020502498 A5 JP 2020502498A5
Authority
JP
Japan
Prior art keywords
protein encoded
group
gene selected
tubb3
hmga2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019528092A
Other languages
English (en)
Japanese (ja)
Other versions
JP7115756B2 (ja
JP2020502498A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/080414 external-priority patent/WO2018096117A1/en
Publication of JP2020502498A publication Critical patent/JP2020502498A/ja
Publication of JP2020502498A5 publication Critical patent/JP2020502498A5/ja
Application granted granted Critical
Publication of JP7115756B2 publication Critical patent/JP7115756B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019528092A 2016-11-25 2017-11-24 ヒトの皮膚の老化の新規バイオマーカー Expired - Fee Related JP7115756B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16306561 2016-11-25
EP16306561.8 2016-11-25
PCT/EP2017/080414 WO2018096117A1 (en) 2016-11-25 2017-11-24 New biomarkers of human skin aging

Publications (3)

Publication Number Publication Date
JP2020502498A JP2020502498A (ja) 2020-01-23
JP2020502498A5 true JP2020502498A5 (https=) 2021-01-14
JP7115756B2 JP7115756B2 (ja) 2022-08-09

Family

ID=57517827

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019528092A Expired - Fee Related JP7115756B2 (ja) 2016-11-25 2017-11-24 ヒトの皮膚の老化の新規バイオマーカー

Country Status (7)

Country Link
US (1) US20210109111A1 (https=)
EP (1) EP3545301A1 (https=)
JP (1) JP7115756B2 (https=)
CN (1) CN110268263B (https=)
CA (1) CA3041959A1 (https=)
RU (1) RU2019116069A (https=)
WO (1) WO2018096117A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112272775A (zh) * 2018-06-04 2021-01-26 雅芳产品公司 用于鉴定和治疗衰老皮肤和皮肤病症的蛋白生物标志物
JP7633003B2 (ja) * 2019-11-29 2025-02-19 ポーラ化成工業株式会社 抗老化成分のスクリーニング方法
WO2023090901A1 (ko) * 2021-11-18 2023-05-25 의료법인 성광의료재단 기계 학습을 이용한 세포 노화의 마커를 선별하는 방법, 세포 노화 바이오 마커, 및 이를 이용한 세놀리틱 제제를 스크리닝 하는 방법
KR20240146665A (ko) 2022-01-07 2024-10-08 오디티 랩스, 엘엘씨 피부 치료를 위한 조성물, 제제 및 방법
JP2023130972A (ja) * 2022-03-08 2023-09-21 株式会社 資生堂 黄ぐすみ抑制方法、黄ぐすみ抑制剤のスクリーニング方法、及び黄ぐすみ感受性の評価方法
CN121208353A (zh) * 2025-08-22 2025-12-26 北京大学第一医院(北京大学第一临床医学院) 一种辅助诊断pcos自发性早产的蛋白质生物标志物及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001068804A2 (en) * 2000-03-10 2001-09-20 Lifespan Biosciences, Inc. Nucleic acid sequences associated with aging, particularly skin aging
DE10100121A1 (de) * 2001-01-03 2002-08-01 Henkel Kgaa Verfahren zur Bestimmung des Hautstreß oder der Hautalterung in vitro
WO2004061456A2 (de) * 2003-01-03 2004-07-22 Alcedo Biotech Gmbh Verwendungen von hmgb, hmgn, hmga proteinen
WO2004083398A2 (en) * 2003-03-17 2004-09-30 The Government Of The United States Of America As Represented By The Secretary Of Department Of Health And Human Services Therapeutic uses of hmgn1 and hmgn2
KR101318521B1 (ko) * 2005-08-23 2013-10-16 가오루 미야자키 피부 노화 마커와 그의 이용기술
US8859021B2 (en) * 2007-05-14 2014-10-14 Sytheon Skin appearance through gene manipulation
KR100999261B1 (ko) * 2007-10-09 2010-12-07 (주)아모레퍼시픽 여성호르몬 결핍으로 초래되는 여성 피부의 노화 억제제 스크리닝 방법
FR2925313A1 (fr) * 2007-12-19 2009-06-26 Oreal Utilisation cosmetique de proteines de type plakoglobine
US20120034613A1 (en) * 2010-08-03 2012-02-09 Nse Products, Inc. Apparatus and Method for Testing Relationships Between Gene Expression and Physical Appearance of Skin
WO2012151346A1 (en) * 2011-05-03 2012-11-08 Dermachip Inc. Expression signatures of genes and gene networks associated with skin aging
EP3287782B1 (en) * 2013-03-15 2020-04-22 The Procter & Gamble Company A noninvasive method for measuring antimicrobial peptides from skin as an objective measurement of natural protection from microbes

Similar Documents

Publication Publication Date Title
JP2020502498A5 (https=)
US20240079089A1 (en) Immunotherapy Markers And Uses Therefor
Wong et al. Cell-free DNA in maternal plasma and serum: A comparison of quantity, quality and tissue origin using genomic and epigenomic approaches
RU2019116069A (ru) Новые биомаркеры старения кожи человека
Zhang et al. Linc‐MAF‐4 regulates Th1/Th2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF
Davar et al. Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
JP2014521308A5 (https=)
RU2012125253A (ru) Система для увеличения экспрессии генов и вектор, содержащий указанную систему
JP7390002B2 (ja) 頭頸部がんの検出を補助する方法
KR20180087244A (ko) 체크포인트 억제제에 대한 감도를 예측하는 msi 및 네오에피토프를 발견하기 위한 위한 시스템, 조성물 및 방법
JP7797199B2 (ja) 子癇前症に特異的な循環rnaシグネチャー
JP2015530877A5 (https=)
Xu et al. FOXF2 aggravates the progression of non-small cell lung cancer through targeting lncRNA H19 to downregulate PTEN.
JP2022513068A5 (https=)
Levi et al. p21 facilitates chronic lung inflammation via epithelial and endothelial cells
Renhua et al. 165P: Long noncoding RNA LUCAT1 is associated with poor prognosis in human non-small cell lung cancer and affects cell proliferation via regulating p21 and p57 expression
JP2017528114A5 (https=)
Maggi et al. Technological advances in precision medicine and drug development
CN104131113B (zh) 一种miRNA检测试剂盒及其应用
CN106399550A (zh) 检测外周血CAR‑T细胞的TaqMan实时荧光定量PCR试剂盒
CN106222242A (zh) 长链非编码rna-apoc1p1-3基因及其在用于制备靶点标志物中的用途
US11844809B2 (en) Strategy to increase anti-viral, anti-microbial, and anti-fungal defense
JP2012521549A5 (https=)
JP2022509018A (ja) 放射線誘発肺障害のためのバイオマーカー及び使用方法
KR102083956B1 (ko) 다발성 골수종 환자에서 레날리도마이드 및 덱사메타손의 치료에 대한 예후 예측용 바이오 마커